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(http://creativecommons.org/licenses1 There is no official tally of the total number of IVF babies in
China. China’s largest clinic in Changsha had helped bring 73,461 IVF
babies to term by March 2015.Introduction
There is an almost precise coincidence of timing in the birth
of Louise Brown in July 1978 and the implementation of
China’s restrictive family planning policy a few months
later in 1979. These two landmark events stand at odds with
each other in many ways. For Robert Edwards and Patrick
Steptoe, the two doctors who helped Lesley and John Brown
give birth to Louise using the technique of IVF, infertility was
the problem that needed to be overcome. In contrast, for
systems engineer Song Jian, mathematician Li Guangyuan
and other architects of China’s so-called ‘one-child policy’,
excessive fertility was the problem that needed to be curbed6.09.002
ed by Elsevier Ltd. This is an open
/by-nc-nd/4.0/).(Greenhalgh, 2008). The technique of IVF alone has brought
an estimated 5 million babies into the world globally (of
which some 200,000 in China, based on my best estimate
after visiting various fertility clinics in the country1) while
it is said that the ‘one-child policy’ has prevented some
140 million births in China.
It is worth remembering that, as Martin Johnson and
colleagues have shown (Johnson, 2011; Johnson et al.,
2010), Edwards and Steptoe faced numerous setbacks duringaccess article under the CC BY-NC-ND license
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refused funding by the Medical Research Council in the early
1970s in a scientific climate where research into infertility
‘was accorded a low priority’ when compared with contra-
ception and abortion (Johnson et al., 2010: 2158). Similarly,
beginning in the early 1980s, reproductive scientists Lu
Guangxiu, Zhang Lizhu and He Cuihua also faced many
setbacks, albeit eventually securing government funding
for their research in 1986, in a country where concerns
about overpopulation were immediately national rather
than global.
In her pioneering ethnographic research carried out in
the early 1990s as a ‘post-1980 consumer market for infer-
tility treatment’ was emerging in Beijing, anthropologist
Lisa Handwerker showed how a growing use of assisted
reproductive technology ‘exacerbated the old social tension
of reproducing the patrilineal line’ (Handwerker, 2002:
306; see also Handwerker, 1995a,b, 1998, 1999). While the
stigma that surrounds infertility and the pressure to do
everything to overcome it was nothing new in China, through
interviews with infertile women and men, Handwerker
found that the one-child policy had in effect come to be
experienced by couples as a ‘must have one child’ policy;
with stories celebrating ‘miraculous’ test-tube babies cir-
culating through media, couples, households and especially
women felt an intensified stigmatization of childlessness.
Handwerker had done her fieldwork in Beijing in the years
immediately following the birth of China’s first IVF baby in
1988. Even in these early days Handwerker described how
‘clinics are overflowing with patients seeking out [assisted
reproductive technology] services, and doctors are trying to
keep up with the demand’ (ibid.). As will now be shown,
such trends have grown almost exponentially since, yet
curiously we have seen no attention by social scientists to
the routinization of IVF in China. More recently, Lijing Jiang
(2015) has provided a historical account of Professor Zhang
Lizhu’s laborious efforts to achieve the birth of China’s
first IVF baby in the 1980s. There have also been a few
anthropological studies of selective reproductive technology
(SRT, used to prevent or allow the birth of certain kinds of
children, such as those with Down syndrome, or a ‘saviour
sibling’ or a boy) (Gammeltoft andWahlberg, 2014) rather than
assisted reproductive technology (used to overcome biological
obstacles to reproduction) notably by anthropologists Jianfeng
Zhu (2013), Suli Sui and Margaret Sleeboom-Faulkner (2010),
Sui (2015). These scholars have provided accounts of how
families engage with SRT such as carrier testing and prenatal
screening in a national context where the state actively
promotes improvement of population quality (renkou suzhi).
This article picks up on the early ethnographic work
by Handwerker carried out in the 1990s as well as Jiang’s
historical work which focuses on the 1980s, firstly by
broadening their geographical focus on Beijing to include
the important work carried out by Lu Guangxiu in Changsha
(capital of China’s Hunan province) and secondly by
extending the analysis to the present. As such, this article
tracks the routes of development and routinization of
assisted reproductive technology in China through the
1980s to the present with a specific focus on IVF. In doing
so, it makes two arguments that are relevant for under-
standing how assisted reproductive technology has become
a routinized part of healthcare delivery around the world.Firstly, it argues that over the course of the last three decades,
assisted reproductive technology in China has eventually
settled alongside contraception, sterilization and abortion
as yet another technology of birth control. While this might
seem counterintuitive, this article shows how, following a
period of trying experimentation, these technologies would
have to mould into a suitable form to fit within China’s
restrictive reproductive regulations before gaining formal
authorisation through national law as late as 2003. The
term ‘birth control’ is most often used to describe fertile
couples’ active efforts to prevent unwanted pregnancies
as a matter of (State-stipulated) family planning. However,
if the term ‘birth control’ is understood as ‘control over
reproduction’, it is argued that for increasing numbers of
infertile couples in China, birth control can also describe an
active effort to achieve wanted pregnancies using assisted
reproductive technology to overcome biological obstacles in
order to have ‘one child’ in strict accordance with family
planning policies.
Secondly, this article argues that we need to re-centre
our analyses when accounting for the routinization of
assisted reproductive technology in different corners of the
world such that we follow the transformation of such
technologies from pioneering to mundane within a given
country rather than across borders. As will be seen, the fact
that IVF was developed in the UK did not relieve scientists
of a need for experimentation in China, and hence we
should not view this process as an ‘importation of Western
reproductive technologies’ (Handwerker, 2002: 310; cf. also
Inhorn, 2003). Indeed, if routinization has been a key
ethnographic trope in social studies of reproductive tech-
nologies in Europe and America (see below), then globalisa-
tion has been a key ethnographic trope in social studies
of reproductive technologies in the so-called global South
(Bharadwaj, 2003; Hörbst, 2012; Inhorn, 2003; Roberts, 2012).
With this article I call for a shift in analytical attention to the
routinization of reproductive technologies in all countries,
including those of the so-called South.
When it comes to medical technologies, ‘routinization’
indexes the transformation of a technology from frontier
to mundane, as ‘new technologies must traverse this
continuum, changing from a status of pure experiment
to the standard of care’ (Koenig, 1988: 466). Barbara
Katz Rothman (1993), Marcia Inhorn (1994, 2003), Lisa
Handwerker (1995a,b, 2002), Sarah Franklin (1997; Franklin
and Roberts, 2006), Rayna Rapp (2000) and Gay Becker
(2000) have led the way in the social and ethnographic
study of new reproductive technologies (both assisted and
selective). They showed us how the development and
routinization of technologies such as IVF, amniocentesis or
prenatal genetic diagnosis (PGD), on the one hand, resulted
from complex intersections within and between biomedical
research, healthcare services, policy, social movements,
popular media and more in a particular country, and on the
other, turned them into an important part of the daily lives of
providers, donors, patients and family members alike. Hence,
building on their work, with the term routinization this article
points, firstly, to socio-historical processes whereby certain
forms of medical technology come to be (re-)produced and
entrenched within particular juridical, medical, social, eco-
nomic, cultural and institutional configurations. To account
for the routinization of assisted reproductive technology, we
2 For Zhang Lizhu’s background story I rely on Jiang Lijing’s
extensive account (2015) as well as my own interviews with
members of staff at the Beijing Third Hospital, attendance at
workshops and archival sources.
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refers to all those daily practices through which certain
medical technologies become an established and habituated
part of healthcare delivery, which is to say a standard of care
for a given condition provided in a fixed setting. There is a
daily grind to the emergence of any medical technology, yet
the particular ways in which these daily practices play out
are different from country to country (not least because of
said configurations), and indeed from hospital to hospital
within countries. Finally, for a medical technology to
become routine it must also be a normalised part of daily
life, in the sense that it is available to and used by its
intended users in a routine manner. As Becker has observed,
‘when a specific medical technology is no longer viewed by
medicine as experimental, that technological innovation may
be increasingly accepted by the public and may eventually
be viewed as commonplace’ (Becker, 2000: 13). New
reproductive technologies have tended to go through
variegated patterns of ‘acceptance’ in different countries:
starting from pioneering ‘breakthroughs’, surrounded or
followed by periods of concern and resistance, then
normalisation through regulation and eventually routiniza-
tion as particular procedures are scaled up and made
available. This article will in particular focus on the first
aspect of routinization, namely, tracing the ways in which
assisted reproductive technologies have taken on a particular
form (cf. Knecht et al., 2012) in China on their way to
becoming ‘accepted’.
It begins by looking at how two of the pioneers of
reproductive science in China – Lu Guangxiu in Changsha
and Zhang Lizhu in Beijing – embarked on a collegial yet
competitive race to achieve the country’s ‘first test-tube
baby’, culminating in the birth of two girls: Zheng Mengzu in
March 1988 in Beijing, closely followed by Zhang Minxing in
Changhsa three months later. It then goes on to show how
the 1990s led to the emergence of an unregulated IVF sector
in Beijing and many parts of the country, all the while
Lu Guangxiu in Changsha was effectively prohibited from
providing IVF services. Finally, it shows how IVF, alongside
other assisted reproductive technologies, was eventually
legalised in 2003 by the Ministry of Health, under the
condition that ‘medical staff are not allowed to conduct
ART on people not qualified under… national population
and family-planning legislation and policies’ (P.R. China,
Ministry of Health, 2003a,b: D1).
The article is based on interviews with some of the
pioneers of reproductive technologies in China. Over a
period of 8 years (2007–2014) I had the opportunity to
speak to and interview Lu Guangxiu on numerous occasions
in Changsha, the principle site of my fieldwork. Four of these
interviews were recorded and transcribed. My requests for
interviews with Zhang Lizhu were gently declined because
of her advanced age. I was however able to spend time at,
and speak to staff members of, the Third Hospital in Beijing
where she had worked. A series of TV, radio and journal
interviews with Zhang, available online, were transcribed
and translated. They are referred to by number throughout.
All other interviews were carried out by the author. The
personal recollections of Zhang and Lu especially are used to
narrate the story of the difficult birth and routinization of
assisted reproductive technology in China. At the same time,
their personal recollections are balanced against furtherinterviews with some of the other scientists involved in the
development of assisted reproductive technology, as well
as with Ministry of Health officials who were active in
reproductive research and policy through the 1980s and
1990s, participation in a series of workshops and conferences
on assisted reproduction in China held in Beijing, Shanghai
and Changsha which gave insights into the history of assisted
reproduction technology in these cities, and consultation of
secondary archival sources. This research has taken place in
the form of episodic fieldwork based at the CITIC-Xiangya
Reproductive and Genetic Hospital in Changsha, the capital
of Hunan province, over a eight-year period (2007–2014).
Having worked with Professor Lu Guangxiu on a previous
grant on the ethics of biomedical research collaboration (see
Wahlberg et al., 2013), I was able to initiate this in-depth
study of the routinization of IVF in China. The resulting
dataset of interview transcriptions, scientific reports, media
articles, laws and regulations forms the basis of the analysis
that follows, as it is this data that has allowed me to piece
together the routes of routinization that IVF has followed
in China.Origin stories
Scientific teams, clinics and indeed countries are often
engaged in a race to be the first when it comes to ‘new’ or
‘frontier’ technologies; whether in the UK or in India there is
prestige to be won from achieving a ‘first’ in the ever-growing
field of reproductive technologies (Bharadwaj, 2002; Franklin
and Roberts, 2006). Global ‘firsts’ (such as Louise Brown or
Dolly the sheep) are perhaps the most prestigious, but by no
means at the cost of national ‘firsts’. In China, as already
noted, two scientists have in particular been recognized, not
least through national awards and prizes, as the pioneers of
assisted reproductive technology – Zhang Lizhu of Beijing’s
Medical University Third Hospital and Lu Guangxiu of the
CITIC-Xiangya Reproductive and Genetic Hospital in Changsha.
If assisted reproductive technologies are completely routin-
ized today in China, they were very much experimental
technologies in 1980, which was a pivotal post-Cultural
Revolution year for reproductive science in China. It was in
1980 that the Human Reproductive Engineering Research
Department was founded at the Xiangya Medical College in
Changsha by Lu Huilin, father of Lu Guangxiu. It was also in
that year that Zhang Lizhu, a trained gynaecologist, returned
to prominence as invited speaker on China’s one-child policy
and related public health issues at the United Nation’s Second
World Conference on Women held in Copenhagen.
Yet, Zhang and Lu arrived at assisted reproduction via
very different paths, as endocrinologist and geneticist
(by training), respectively. Having studied gynaecology in
Shanghai, New York and Baltimore through the 1940s,
Zhang took up her first position as resident gynaecological
physician at the Marie Curie Hospital in London in 1949.2 She
returned to China in 1951, eventually becoming the Director
of Gynaecology and Obstetrics at the Peking University Third
100 A WahlbergHospital in 1958. During the 1960s, her endocrinological
research was focused on the increasing numbers of patients
reporting menstrual irregularity in her clinic. By 1965, as
the Cultural Revolution began, Zhang’s international back-
ground was turned against her as she was demoted from
her position as Director and sent to work in the countryside
for a year where she trained so-called ‘barefoot doctors’,
followed by a job as hospital janitor at the Third Hospital
back in Beijing. Zhang was only able to resume her work
as clinician and researcher in 1978 in a newly established
endocrinology laboratory at the Third Hospital once the
Cultural Revolution had ended. This change in fortune was
directly linked to the Four Modernizations programme that
Deng Xiaoping had launched that year to repair some of
the many setbacks that agriculture, industry, defence and
science and technology had suffered during the Cultural
Revolution. Zhang picked up where she had left off,
concentrating on her patients’ menstrual irregularities, a
specialisation that would inevitably draw her into the field
of infertility, as she recalled in an interview with the
Chinese Obstetrics and Gynaecology forum:
My expertise was in reproductive endocrinology. When I treated
patients with period issues in the 1980s, I found that many of
them not only wanted to cure their period problems, but also
mainly wanted to get pregnant. A lot of them had been married
for over two years but still couldn’t get pregnant. Therefore,
I began to look into what was causing their infertility. After
research and analysis I found out it was due to blocked Fallopian
tubes. In most cases this was the major problem. Blocked
Fallopian tubes were mainly an issue in China, which was
completely different from other counties. In China 31.3% of
female infertility was caused by tuberculosis. We proved that
they had tuberculosis through research and biopsy. So this cause
was not necessarily the same as in other counties. The main
clinical manifestation was pelvic adhesions, and the surface of
the ovary couldn’t even be seen.
(Interview 2)
Lu, on the other hand, was introduced to the field by her
father Lu Huilin, one of the founders of medical genetics
in China. Lu Huilin had travelled to the United States
of America in 1924 to further his education at Columbia
University, studying under Thomas Hunt Morgan and Edmund
Beecher Wilson for a Master’s degree in genetics. Armed
with a number of Morgan’s works, such as Human Inheritance
(1924) and Evolution and Genetics (1925), Lu returned to
China in 1929. Disrupted by illness and the Japan-China war
(1937–1945), Lu eventually set about translating Morgan’s
texts in the late 1940s with a view to spreading Morgan’s
theories to a Chinese audience. In 1950, he published a book
on the theory of the gene and Mendelian inheritance which
he began teaching at the medical college in Changsha only
to be widely criticised in a newly communist China which
officially favoured Lysenkoist ideas around the heritability
of acquired characteristics. Once again Lu’s studies and
teaching were interrupted as the Cultural Revolution took
hold in the 1960s. As a result, he shifted his attention to
medical genetics in the 1970s, forming a research group in
Changsha that would develop prenatal diagnosis and genetic
counselling techniques. It was this group that would beformally institutionalised in 1980 as the Human Reproductive
Engineering Research Department of the Xiangya Medical
College. And so Lu Huilin’s interest in reproductive technol-
ogies began to take shape. His initial excitement upon
hearing news of Louise Brown’s birth some months after the
event in 1979 concerned the possibilities of utilising IVF
not so much to overcome infertility but rather as a way
of avoiding transmission of heritable diseases. It was at
this time, in the late 1970s, that Lu Huilin’s daughter, Lu
Guangxiu, would unknowingly be enlisted in China’s efforts
to develop reproductive technologies. As she explained to
me in her office surrounded by a forest of indoor plants one
late afternoon in May 2011:
I was a surgeon in Guangdong in 1979, and at that time, because
my father’s health was not very good, I came back to Changsha
to take care of him. During that time, he posed a question to
me, asking: ‘Do you know how we can get an oocyte?’ I was
astonished to get this question! Because I had never observed
any oocytes during ultrasound and the technical equipment was
also very poor at that time. So, as a surgeon I answered ‘maybe
you have to open the stomach to have this oocyte.’ I also
wondered why he would ask this question. When I came back to
Changsha, I had become a teacher of anatomy. In those days,
I could teach for half of the year and have my own time for the
other half of the year. Being a surgeon was hectic every day, so
I was used to the old busy days. So I felt I had too much free time
and I hadn’t many things to do. So I asked my father why he
asked this question and he said that he would like to try for an
IVF baby. I then said ‘Why don’t you let me have a try?’ But my
father said that I am a surgeon and so I lack basic knowledge of
this research and he would think about it. After several days, he
gave me some examples of what I would meet if I was going to
be engaged in this research, such as the equipment, technology
and knowledge, so all these things, I had to begin from scratch.
‘You will encounter many difficulties and you have to overcome
them’, he told me. I thought about it and also accepted it and
began the research.
And so, Lu Huilin sent his daughter to Beijing on a
three-month study trip in 1980 to learn how to fertilize
eggs and culture embryos from cows, rats and mice. Lu
Guangxiu’s sister was studying at Beijing University at the
time and had many friends and classmates working at the
Chinese Academy of Sciences in the field of genetics.
So, whereas Zhang Lizhu’s attention had been drawn to
infertility by the patients she encountered as a clinical
gynaecologist, Lu Guangxiu was introduced to reproduc-
tive science by her medical geneticist father whose initial
interests focused on the use of reproductive technologies
to engineer and improve the strength of China’s popula-
tion. This intersection of clinical infertility and medical
genetics, as we will see, turned out to be propitious for
the development of assisted reproductive technology in
China.Experimenting
As noted earlier, Zhang Lizhu travelled to Copenhagen
to speak at the United Nations Women’s Conference, yet
101Birth of IVF in Chinaas she has explained, she did not learn about IVF at this
point:
I went abroad in 1980 with some women’s groups to visit many
places. However, our visit at the time didn’t consider test-tube
baby technology at all. What we looked at was how to do female
healthcare, how to do family planning – meaning abortions
and birth control – as well as learning about condoms and
intrauterine devices, therefore we didn’t really keep up with the
trends at the time.
(Interview 4)
As a result, once she did begin focusing her attention on
the infertility problems of her patients which were affected
by the epidemiological particularities of China, she would
have to embark on her own forms of experimentation. Lu
had been astonished when her father had asked her ‘Do you
know how to get an oocyte?’ since she had worked as a
surgeon rather than an obstetrician or gynaecologist. Zhang,
on the other hand had experience from working with her
patients. She recalls how she began working to locate and
retrieve oocytes:
There were test-tube babies elsewhere in the world at this time.
The first test-tube baby was born in 1978 in the UK. At that time
they were all using laparoscopic surgery to retrieve eggs. Once the
laparoscope was put in, the surface of the ovary could be seen, and
the ovary follicle could be seen too,whichwas the place the needle
needed to penetrate. However, in China we couldn’t do the same
because the surface of the ovary couldn’t be seen at all using a
laparoscope. So the only method we had at the time was retrieving
ova by hand while treating pelvic cavity disease. Manually reaching
the ovary follicle and judging by instinct to decide where to insert
the needle, sucking the ovarian follicular fluid out and then finding
the ova in the ovarian follicular fluid. Therefore, we used a
different strategy by finding ova in the ovarian follicular fluid we
retrieved, and learned more about the ova.
(Interview 2)
Jiang has argued that we should take this celebration of an
‘indigenous method’ with a grain of salt, since the fact was
that laparoscopy was a difficult technique for anyone to learn,
let alone in China where clinical and laboratory conditions
were so poor in the early 1980s (Jiang, 2015: 13–14). Open
pelvic surgery was not so much necessary in China at the time
as it was familiar. Moreover, there were not many patients
who were willing to undergo experimental procedures solely
for egg retrieval.3 Instead patients were asked if they would
agree to egg retrieval for research purposes once open pelvic
surgery for a medical indication had been safely completed.
On her part, Lu Guangxiu’s initial attempts to secure oocytes
during this time were also through surgery, because as she
told me ‘we didn’t know how to do laparoscopy’. Zhang has3 Today, ethical review boards have become a required obligatory
point of passage for much biomedical research. In China, such
procedures remain relatively new to the country (see Wahlberg
et al., 2013) and there are certainly numerous questions that can be
raised about the ethics of early assisted reproductive technology
research in China. Such questions are of course equally relevant in
every country where experimental assisted reproductive technology
research has been carried out; whether in India, Denmark or the UK.recounted how in these early years ‘we [started] from not
being able to identify ova’ just as Lu has recalled ‘I didn’t
know what the eggs look like at that time’. As a result, there
was a lot of trial and error involved. For Lu, this involved
countless trips to hospitals throughout Changsha which carried
out surgery for the treatment of gynaecological disease to ask
for assistance in getting oocytes:
Egg retrieval had been done in Xiangya hospital, however as they
didn’t support our work I was refused to go into the surgery
room. I had to go to other hospitals for eggs. I sometimes rode
a bicycle and carried a bucket as I visited many hospitals in
Changhsa. But I had little chance to get eggs, since sometimes
we couldn’t find follicles in ovarian tissues. Besides, it was also
very hard for me to recognize eggs, as human eggs were different
from mice eggs. That’s why I set up a sperm bank at that time,
because I couldn’t tell whether the eggs were mature or immature
when I got eggs, so I had to fertilize the eggs. So I set up a sperm
bank in order to fertilize the eggs once I got them. Without
ovulation induction, it was very difficult at that time.
Zhang on the other hand, was familiar with and had direct
access to the departments at the Third Hospital which
carried out routine open pelvic surgery for a variety of
conditions. Yet, also she would have some trouble finding
willing patients, and when she did there were numerous
practical challenges related to timing operations such that
they coincided with ovulation. Without a sperm bank in
Beijing, Zhang relied on the husbands of her infertile patients
to provide sperm samples, not all of whom agreed. Moreover,
Zhang was also hampered initially by not having seen a
human egg before, having only microscopically observed pig
and mouse eggs. In this way, the early 1980s were truly
experimental years for assisted reproduction in China. Those
scientists who became interested in reproductive technolo-
gies had to devise ways of getting gametes in China, and were
faced with at least as many (if not more) challenges in this as
their colleagues anywhere else in the world.
Indeed, visiting China’s gridlocked metropolises today
it can be easy to forget just how much cities like Beijing
and Changsha have transformed over the last 25 years.
Following the Cultural Revolution, which ended in 1976,
many laboratories had become almost derelict and there
were no reliable suppliers of laboratory equipment or chemical
agents. The bicycle was still the most common form of urban
transportation. In recollections of the many difficulties they
had faced, both Zhang and Lu convey a sense of pride and
perhaps also nostalgia for the excitement of the times. Zhang
has recalled howequipment shortageswere a constant struggle
when they were trying to develop egg retrieval techniques:
We described the difficulties we faced as ‘poor and blank’.
Conditions were really poor. All equipment had to be used
repeatedly. For example, there were only a few ova-retrieving
needles, which were brought back from overseas. They had to be
washed and high-pressure sanitized. Vessels had to be used again
and again too, and then washed and high-pressure sanitized. At
that time we had a lot of cases but there were no infections. This
was very impressive and staff in our laboratory worked really hard.
There were whorls at the very top of the needles… which made it
easy to knowwhere to penetrate. The whorls were worn down. We
took the needles to watchmaker shops to sharpen them. After
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away, since the whorls could barely be seen anymore. The
conditions really were poor at the time.
(Interview 1)Improving population quality
By 1984, Zhang had developed her own technique of egg
retrieval, just as Lu had established China’s first sperm bank
and secured China’s first child using frozen sperm. Up to
that point, the two had operated without much knowledge of
each other’s work. That would change in late 1983 when an
exhibition on ‘superior births’ (yousheng)4 was organised by
the Family Planning Department of the provincial government
in Hunan province. Participants at the exhibition discussed
both ‘negative’ (primarily prenatal diagnosis followed by
abortion) and ‘positive’ ways of improving population quality.
Since preimplantation genetic diagnosis was a long way off at
that stage, sperm banking was discussed as one possible
method of improving population quality. A group of journalists
who were attending the exhibition got wind that a sperm bank
had in fact been established in Changsha:
They came here for an interview and then they sent out a report
saying that in Hunan there is a sperm bank. This was kind of
explosive news in China, because every newspaper carried this
information and they kept reporting it, and suddenly we got very
famous around China! [laughter] and we got hundreds of letters
from patients and from other institutes. Although many people
praised us, some people criticized us… they thought we were
treating people like animals, since we are just collecting sperm.
Shortly after news of Changsha’s sperm bank had broken
nationally, Zhang Lizhu and Lu Guangxiu began communi-
cating. Together with He Cuihua from the Peking Union
Medical College (who had been introduced to assisted
reproduction during a study trip to Singapore), the trio agreed
to prepare an application for research funding which would be
sent to the Ministry of Health. After some discussion between
them, they agreed to title their application ‘Yousheng: The
Protection, Preservation, and Development of Early Embryos’,
a decision that cannot be detached from the family planning
measures that were being rolled out across China in this exact
same period, as well as the growing interest in population
quality on the part of Family Planning officials5 (GreenhalghYousheng is often translated as ‘eugenics’ but as noted above, it
ore accurately translated as ‘excellent’ or ‘superior’ birth and is
d to describe all efforts aimed at ensuring the birth of a healthy
ld, from genetic counselling to taking care of oneself during
gnancy, prenatal care and screening (Sleeboom-Faulkner, 2010;
hlberg, 2010).
The debate overwhether yousheng should be understood and directly
nslated into English as ‘eugenics’ has been ongoing ever since the
ernment proposed a law on yousheng in 1994. The term ismade of the
characters for you which translates as ‘superior’ and sheng which
nslates as ‘birth’. The title of this law was later changed to the
aternal and Infant Health Care law” not least as a consequence of
rnational controversy, although the law clearly states that improving
ulation quality through the prevention of congenital birth defects and
ious genetic disease is amajor objective. It is beyond the scope of this
er to contribute to this discussion. For ethnographic engagementwith
na’s yousheng policy see, P.R. China (1994), among many others, Zhu
13), Wahlberg (2010), Sleeboom-Faulkner (2010) and Sui (2015).and Winckler, 2005). As Zhang has put it ‘there were other
voices at the time. Some people said: China already has such a
huge population, why do you still want to work on test-tube
babies? They said this went against the national family
planning policy.’ (Interview 1). Similarly, when I asked Lu
about the apparent contradictions of carrying out IVF research
in China in the 1980s she replied ‘there weremany doctors and
researchers who asked the same question as you did just now.
So under this population policy and we are doing this kind of
technology, something which is contradictory’. Moreover, as
we saw earlier, Lu Guangxiu’s route to reproductive science
had been through medical genetics and her team at the
Human Reproductive Engineering Research Departmentwas as
engaged in prenatal genetic testing as it was in IVF research.
The medical genetic potentials of reproductive technologies
had been at the very core of Lu Huilin’s and Lu Guangxiu’s
early engagements with reproductive science. In the way in
which their research application was framed, reproductive
technologies emerged as techniques that could potentially
contribute to the improvement of population quality in
China (rather than being an infertility treatment as such), a
demographic aim that had become a primary family planning
objective alongside the controlling of population growth
(Greenhalgh, 2008; Jiang, 2015; Sleeboom-Faulkner, 2010;
Wahlberg, 2010).
If Zhang had succeeded in refining techniques to identify
and retrieve human oocytes with the help of Liu Bin by 1984,
having witnessed the great difficulties that his daughter was
facing in trying to get gametes and equipment for fertiliza-
tion research, Lu Huilin conceded in that same year. ‘My
father said that we can’t go on like this, so he told the
university that I need to have some training in foreign
countries.’ Arrangements were made for Lu Guangxiu and
her colleague Xu Lili to travel to Yale University, a long-time
partner of the Xiangya Medical College, in 1985. Lu was
charged with learning laboratory procedures such as sperm
washing, determination of the level of maturity of an egg,
culture medium preparation as well as embryo morphology
assessment, while Xu on the other hand received training
in clinical procedures such as ovarian stimulation and egg
retrieval. Six months later, the pair returned to Changsha
bringing back with them as much equipment as they could
carry including electronic scales, an osmotic pressure tester
and even a bottle of ultrapure water: ‘I came back in
1986 and established a laboratory immediately with all the
equipment’. Now, one might be tempted to argue that
clearly Lu Guangxiu, Zhang Lizhu and He Cuihua had received
training and inspiration outside of China, hence perhaps
this is after all a story of ‘importing western technologies
into China’. However, we know that, for example, Robert
Edwards and Patrick Steptoe interacted with numerous
international colleagues, and Steptoe travelled to France to
learn laparoscopy from Raoul Palmer (Litynski, 1998), yet it is
the UK that is most often ‘credited’ as the ‘birthplace’ of IVF.
My point is that regardless of where they received training
and where successful IVF was first achieved, Lu and Zhang
had to experiment in order to develop it in China; they were
not able to ‘skip’ experimentation and merely set about
routinizing IVF. Moreover, in setting out to develop repro-
ductive technologies in China they were responding to local
concerns arising out of the clinic (in Zhang’s case) as well as
out of a growing interest in population quality on the part of
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Edwards and Steptoe, Zhang and Lu built upon a range of
already established procedures, technologies and lab
equipment which were circulating through global flows
of technology and knowledge as they developed IVF in
China.
It was also in 1986 that the ‘Yousheng’ research project
would receive funding from the National Natural Science
Foundation of China, which had been established under
the auspices of the Four Modernizations programme. The
Foundation awarded RMB 100,000 to be split between the
three researchers and their laboratories. The amount was
therefore hardly sufficient, although the recognition that
came with being awarded such a grant was perhaps of even
more importance as theirs became a so-called key research
project of the Seventh Five-Year Plan. Reproductive science
had become a part of China’s overall modernization pro-
gramme, just as the race to produce China’s first IVF child was
in effect on. This time, Zhang won. After thirteen attempted
cycles with different women, 39-year-old Zheng Guizhen from
Gansu became pregnant and gave birth to Zheng Mengzu on
10 March 1988 in Beijing: ‘there were three hospitals at
the time working on this... We were the first to produce
test-tube babies’ (Interview 1). In a television programme
called ‘Fendou’ aired on China’s CCTV network in August 2011,
Zhang tells of her nerves on the scheduled day of Zheng
Mengzu’s birth by Caesarean section as the nation’s eyes were
fixed on her:
When the first test-tube baby was born, there were a lot of
reporters waiting outside the operating room. So when I was on
the way to the operating room I didn’t really want to face them.
I passed by with a blank face without even nodding at them,
without a word, because I was worried. I was not worried about
the operation. What I was worried about was the baby being born
with some kind of malformation, such as a harelip. So this is what
I was worrying about when I performed the surgery. Then I saw
the baby and checked her whole body and she was totally fine,
crying really loudly. I felt I could relax afterwards. They said at
this point I looked happy, with a little smile. So I really didn’t
know how to cope with the media at the time. I should have
talked to them a little bit, which I didn’t do at all.
(Interview 3)
It is telling that the health of Zheng Mengzu was foremost
on Zhang’s mind. Since Zhang, Lu and He had claimed
that IVF was a technique that would contribute to ‘superior
births’ (yousheng), it would have been a major setback had
the child not been healthy. Meanwhile, in Changsha, yet
another ‘race’ was playing out:
We didn’t succeed for more than one year [after returning from
Yale in 1986], so I worried much about that. The country had spent
somuchmoney onmy training and there were a lot of expectations
on me from others, especially frommy father. He was 88 years old
at that time, so I also hoped to succeed as soon as possible.
However, I failed for over one year so that I felt a lot of pressure.
Changsha’s first IVF babies were finally born three
months after Zheng Mengzu in June of 1988. As it happened,
two patients had had their eggs retrieved and fertilized
around the same time in the second half of 1987. Once theireggs had been fertilized with their respective husbands’
spermatozoa, one of the patients had only very poor quality
embryos while the other patient had surplus good quality
embryos. However, since:
there was no freezing equipment and technology, we usually had
to abandon the spare embryos. Instead, we asked her [the
woman who ‘only’ had poor quality embryos] if she would like to
accept the other couple’s embryo, she said yes. Actually she was
the first one who got pregnant in our centre… We don’t know
how we succeeded in the first one, maybe it’s because we had
done this work for a certain time and had gained some
experience. However, the success rate at that time was still
very low and it was probably less than 5%.
And so, Zhang Minxing, Changsha’s first IVF baby (China’s
second) was born on the 5 June 1988, closely followed by Luo
Youqun China’s first embryo donation baby on the 7 June
1988. In all, a flurry of four IVF babies were born in 1988, two
in Beijing and two in Changsha. Both Zhang and Lu had used
open pelvic surgery to retrieve eggs in their first successful
IVF cases. He Cuihua had used laparoscopic methods to try to
obtain eggs and was ultimately unsuccessful in her quest
for a ‘first’ IVF baby at the Peking Union Medical College in
the late 1980s.Legalisation
While the births of the first IVF babies in China were widely
celebrated in the media as examples of China’s indigenous
scientific capabilities (Jiang, 2015), it would take a further
fifteen years before assisted reproductive technology would
finally be legalised and thereby authorised in China. Indeed,
the 1990s turned out to be very different for Zhang than for
Lu. In Changsha, provincial Ministry of Health officials had
made it clear to Lu and her team that they were not in
favour of assisted reproduction. They did have an interest in
the potentials of SRT for improving population quality, but
when it came to helping couples to have babies they felt
that this was at odds with their systematic efforts to bring
down fertility rates. As one scientist who had been working
in Changsha at the time explained to me, some government
officials ‘had opinions about if we still have this kind of
technology, then we will increase the population and because
of this, Hunan province also issued a regulation to prohibit
artificial insemination technology.’ Indeed, on 3 December
1989, reproductive technologies were targeted for the first
time in Hunan’s provincial Family Planning Regulations, issued
at the twelfth meeting of the Seventh People’s Congress
Standing Committee of Hunan in Changsha. The preamble
of these regulations state that the overall objective of
family planning in Hunan is ‘to control population growth
and improve population quality [through] late marriage and
childbearing with yousheng births’ (Hunan, 1989: §1.1, 1.3).
Article 25 specifically prohibits ‘fetal sex identification for
pregnant women’ and ‘artificial insemination’, the latter of
which was included as a direct consequence of the national
media notoriety that Changsha had attained for having China’s
first sperm bank as well as for delivering two IVF babies.
No other provinces would legally ban assisted reproduction in
this way. The impact that this regulation had was immediate.
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continuing to work with patients, and so for most of the 1990s,
reproductive research and experimentation in Changsha was
confined to animals and basic research.
In stark contrast, Zhang was able to continue developing
assisted reproductive technology treatments in Beijing as
her stature had grown immensely following the birth of
Zheng Mengzu and she continued to receive support from the
central government. Zhang’s achievement had been cele-
brated widely in the media as an example of indigenous
scientific capacity (Jiang, 2015). As I learned from Qiao Jie,
Director of the Medical Centre for Human Reproduction at
the Third Hospital who worked under Zhang in the 1990s,
Zhang went on to deliver China’s first frozen embryo baby as
well as China’s first baby through gestational surrogacy in
the first half of the decade. By 1993, some 50 IVF babies had
been born in China, mostly in Beijing. Yet Zhang would still
have to justify her work to those colleagues, government
officials and journalists who:
asked how the country benefited from test-tube babies. Of course
it was hard to say what benefit it brought to the country. However,
people are part of this country. There is no country if there are no
people. Test-tube babies brought happiness to many people. If
people have a need like this, then we should fulfil it for them.
People did have this need, and some of them needed it urgently.
We received 6,300 letters from people who were infertile [in the
years following Zheng Mengzu’s widely publicised birth]. We
analysed these letters and a lot of them had really hard lives:
lots of people had extremely low self-esteem; the relationship
between husband and wife was really bad; some divorced; some
had family conflicts and didn’t work anymore. This affected
society’s harmony, and this is in the end related to the country.
(Interview 1)
Back in Changsha, Lu Guangxiu had not given up her hopes
of establishing a fertility clinic, and as the decade wore on,
the increasing growth of assisted reproductive technologies
in the rest of the country would lead to a lifting of the
ban on artificial insemination in Hunan. Clinics were being
established throughout China in the 1990s. One reproductive
scientist I interviewed in Changsha suggested that, ‘some
experts also said that 1997 was a Chinese IVF year because in
that year, many centres appeared at the same time. So
these centres were also kind of promoting the development
of IVF technology’. Bolstered by these developments, Lu and
her team continued to lobby provincial government officials
in Hunan to get them to change their position on assisted
reproduction. Meetings and workshops were organised in
Changsha with the participation of local family planning
officials, Ministry of Public Health representatives as well as
legal advisers. Lu explained her tactics at these meetings:
I told them that my opinion is that the population policy requires
that every family has only one child, but this is for fertile couples
then you have one child. But for infertile couples we should
also help them to have one healthy baby. So this is the real
population policy. So I told the Family Planning bureau in Hunan
that our population policy should be based on this idea that
every family should have one healthy baby, not only fertile, but
also infertile couples, so this is fair to every family.
(see also Wahlberg, 2014)On 3 August 1999, Hunan’s Family Planning regulations
were amended. This time Article 23 stated ‘artificial
insemination is prohibited, with the exception of institutions
approved by the nation for scientific research, and those
approved by family planning administration departments
of the provincial people’s government’ (Hunan Province,
1999). But it was not only Family Planning and Ministry of
Health authorities in Hunan that had taken note of the
growing yet-unregulated assisted reproductive technology
sector in China. During one of my stays in Beijing as a Visiting
Scholar at the Peking University Health Science Centre in
2007, just opposite the fertility clinic at the Third Hospital,
I interviewed one of the Ministry of Health officials in Beijing
who coordinated the drafting of national regulations for
assisted reproductive technologies. I was told how:
We carried out a survey in 1999 where we found out that about
200 centres were offering assisted reproductive technologies,
but the standards were not good and they were not regulated.
This was not acceptable. That’s why we decided to put an expert
group together to prepare regulations for these technologies, so
that these clinics would require a license to provide assisted
reproductive technologies.
And so it was, as the Ministry of Health issued a set
of laws, regulations and technical specifications during the
period 2001 to 2003 that would finally legalise assisted
reproductive technology nationally. These included the
Regulation on Assisted Reproductive Technology and Ethical
Principles for Human Assisted Reproductive Technology and
Sperm Banks, both of which were issued in 2001 and revised
in 2003. With these regulations, assisted reproduction had
finally settled into a form that suited the country’s repro-
ductive regulations. Henceforth, clinics providing assisted
reproductive technology would have to live up to a series of
strict requirements in order to be licensed. Apart from a
number of technical requirements concerning the equip-
ment, procedures and personnel that clinics must have,
what made these regulations distinctive to China was the
following passage:
Organizations operating IVF-ET [embryo transfer] and related
technologies, must obey national population and family-planning
legislation and policies… Organizations must first carefully
inspect a couple’s ID, marriage certificate and original copy of
their qualification of pregnancy certificate issued under national
population and family-planning legislation and policies. Photo-
copies of the mentioned documents should be saved for the
records. (P.R. China 2003: B1, B2)
As a result, IVF and other assisted reproductive technol-
ogies (such as insemination and gamete intra-Fallopian
transfer) are now only available to couples who have both
a marriage certificate and a pregnancy certificate. The
impact of the 2003 revised regulations on assisted repro-
ductive technology was immediate. Only 90 of the 200 or so
clinics that were providing assisted reproductive technology
at the time were able to match the licensing requirements
stipulated in the regulations. The regulations also served to
normalise the practice of assisted reproductive technology.
This normalisation was vividly on display in the lobby of one
of the provincial Family Planning hospitals that I visited. The
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confirmed that among the services on offer were IVF, human
sperm bank, prenatal screening, ligation operations, ligation
reversal operations as well as pregnancy terminations. In
this way, assisted reproductive technology has become but
one among many other techniques of birth control which aim
to control population growth and improve population quality
in China.Scaled-up IVF
Since 2003, the number of clinics providing assisted
reproductive technology under license has steadily climbed
back to and surpassed the 200 that the Ministry of Health
had identified in their 1999 survey. By 2014, an estimated
400 centres were offering assisted reproductive technology
services. In Beijing, the number of IVF babies has
skyrocketed from the 50 reported by Handwerker in the
early 1990s to more than 10,000 in 2011. In 2002 in
Changsha, Lu and a group of investors formed the
CITIC-Xiangya Reproductive Genetic Hospital which has
exponentially increased the number of IVF cycles annually
from 2,000 in 2003 to 30,000 in 2014. Scaled-up IVF is now a
reality in China with profound implications for the ways in
which the logistics of IVF are organized and patients
experience their treatments. Growth continues to be driven
both by insatiable demand (in Beijing and Changsha, huge
crowds congregate every morning hoping to register as
patient-customers) and because assisted reproductive
technology has become a very lucrative sector with private
investors providing much of the capital required to get
started and/or expand.
According to Ministry of Health statistics, in 2013 there
were a total of 609,009 assisted reproductive technology
cycles carried out in China (including artificial insemination
by husband: 91,725; artificial insemination by donor:
30,229; IVF: 221,025; intracytoplasmic sperm injection
(ICSI): 98,935; and frozen embryo: 167,095). These cycles
resulted in 193,863 pregnancies in 2013 and there were
145,108 live assisted reproductive technology births in that
year too. The estimated cost per IVF cycle is 20,000 to
30,000 RMB while for ICSI it is 25,000 to 35,000 RMB per
cycle. Fertility treatment is not covered by public or private
insurance which means that for many infertile couples in
China, assisted reproductive technology remains out of
reach.
In one of the newest fertility clinics I visited in China, the
IVF laboratory was surrounded by no fewer than four egg
retrieval/embryo transfer theatres, each with a hatch into
the laboratory. On my tour of these facilities when I asked
what couples did with any so-called ‘spare embryos’ if
they succeeded in having a child, given the then one-child
policy, one of the embryologists exclaimed that ‘our tanks
are bursting!’. As it happens, many couples had been
(cryo-)banking on a change in family planning regulations
as indeed did happen in late 2015 when all couples were
given permission to have two children, changes that made
these frozen embryos bureaucratically viable for the first
time. While the scale of assisted reproductive technology in
China may appear enormous to most, it does not seem out of
place when compared with other forms of health deliveryand hospital care in China. If we accept estimates that
some 10% of couples of childbearing age are having trouble
conceiving without assistance in China, the maths speaks for
itself.
Conclusion
In the space of three decades, IVF in China has gone from
experimental to routinized on an astounding scale and it has
traversed the continuum from experimental to standard care
within the country. It is absolutely the case that Zhang,
Lu and others had received training and inspiration interna-
tionally, but in no way did this training allow them to
‘merely’ introduce and adapt an already existing technology
to fit China’s social, cultural, legal and socio-economic
situation. Even if IVF had been invented and developed in
isolation in the UK in 1978, it was not a case of simply
importing a pre-existing technology into China; rather,
bound up in global flows of knowledge and technology
(much like all other scientists in the world), Zhang and Lu
experimented in conditions that were extremely crude in
comparison to those found in Europe in the 1970s. Following
this experimentation in the 1980s, it would take almost two
decades before IVF was officially accepted and sanctioned
through assisted reproductive technology legislation amidst
much resistance and scepticism on the part of government
officials as well as fellow scientists. Since assisted repro-
ductive technology was shaped into a suitable form via the
2003 regulations requiring couples to present clinics with
their ‘qualification of pregnancy certificate’, we have seen a
globally unprecedented scaling up of assisted reproductive
technology in China. Notwithstanding this growing sector,
clinics simply cannot keep up with demand. Yet, as I have
shown in this article, the routinization of assisted reproduc-
tive technology has by no means been self-evident or an
unavoidable consequence of globalisation. Lu, Zhang and
other reproductive scientists were not somehow ‘adapting’
a western technology; instead IVF emerged in China in
response to local concerns (not least tuberculosis-induced
infertility and a governmental push to improve population
quality) in a way that makes it best understood as a technology
of birth control.Acknowledgements
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